Remi A. Nout - Concepedia

Author

Remi A. Nout

Also Known As

Carien L. Creutzberg, J.W.M. Mens, Nout, R.A., Nout, RA, Nout, Remi, Nout, Remi A., R A Nout, R Nout, R. A. Nout, R. Nout

561

Publications

26.6K

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center University Medical Center Utrecht Institut Gustave Roussy Medical University of Vienna Erasmus MC Cancer Institute

About

Remi A. Nout is an author at Leiden University Medical Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	68	12.4K
2	Health Sciences	22	26	2.6K
3	Public Health	11	11	1.7K
4	Social Sciences	1	1	212
5	Anesthesia	1	1	90

Remi A. Nout

142

Publications

19.9K

Citations

H-Index

Page 1

	Year	Citations
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma Nicole Concin, Xavier Matías‐Guiu, Ignace Vergote, International Journal of Gynecological Cancer Endocrine-related CancerMedicineCancer ManagementGynecologyEsgo/estro/esp Guidelines	2020	1.8K
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up Nicoletta Colombo, Carien L. Creutzberg, Frédéric Amant, Annals of Oncology Gynecological SurgeryMedicineGynecologyEndometrial CancerOncology	2015	1.4K
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts Ellen Stelloo, Remi A. Nout, Elisabeth M. Osse, Clinical Cancer Research	2016	819
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy Alicia León‐Castillo, Stephanie M. de Boer, Melanie Powell, Journal of Clinical Oncology	2020	777
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer Nicoletta Colombo, Carien L. Creutzberg, Frédéric Amant, International Journal of Gynecological Cancer	2015	745
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial Stephanie M. de Boer, Melanie Powell, Linda Mileshkin, The Lancet Oncology	2018	599
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study Richard Pötter, Kari Tanderup, Maximilian Schmid, The Lancet Oncology Adaptive RadiotherapyAdvanced Cervical CancerCervical CancerMedical ImagingRadiation Therapy	2021	583
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative Ellen Stelloo, Tjalling Bosse, Remi A. Nout, Modern Pathology Targetable PathwaysTransportec InitiativeHigh-risk Endometrial CancerMedicineCancer Management	2015	476
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer David Cibula, Richard Pötter, François Planchamp, International Journal of Gynecological Cancer Cervical Cancer ScreeningCervical Cancer ManagementCervical CancerCervical HealthGynecological Surgery	2018	470
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial Stephanie M. de Boer, Melanie Powell, Linda Mileshkin, The Lancet Oncology	2019	432

Page 1